GSK

Showing 15 posts of 760 posts found.

GSK image

GSK announces AllTrials support

February 6, 2013
Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre

GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …

GSK slams Guardian article

January 31, 2013
Sales and Marketing Avandia, FDA, GSK, Guardian

GlaxoSmithKline has slammed an article about its controversial diabetes treatment Avandia in The Guardian newspaper, saying that some of it …

hans_wijers

GSK appoints Hans Wijers to its Board as a non-executive director

January 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, hans Wijers

GSK has confirmed the appointment of Hans Wijers to its Board as a non-executive director with effect from April.  The …

GSK image

EU submission for GSK and Theravance COPD drug

January 11, 2013
Sales and Marketing COPD, GSK, Theravance, UMEC/VI

GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …

Revolade image

GSK’s Promacta extends US licence

November 22, 2012
Sales and Marketing FDA, GSK, Promacta, Revolade

GlaxoSmithKline’s Promacta has received a new indication from the FDA which means it can be used for patients with thrombocytopenia …

Pfizer image

Pfizer and GSK end agreements

November 12, 2012
Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport

Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …

Revolade image

GSK guilty of off-label promotion

November 9, 2012
Medical Communications, Sales and Marketing GSK, PMCPA, Revolade

GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …

janssen image

Janssen and GSK in hep C tie-ups

November 8, 2012
Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …

gsk image

GSK hit by European austerity again

November 1, 2012
Sales and Marketing Europe, GSK, Q3, austerity

GlaxoSmithKline suffered in the third quarter as sales fell 5% due to generic competition and austerity measures in Europe.Exceptional sales …

Reprieve for GSK’s Sligo plant

October 16, 2012
Manufacturing and Production GSK, Ireland, Sligo, cuts

GlaxoSmithKline has reversed its earlier plan to close a manufacturing plant in Sligo, Ireland, and says it now intends to …

GSK image

GSK signs TB vaccine agreement

October 11, 2012
Research and Development, Sales and Marketing Aeras, GSK, TB

GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …

Digital awards image

Vernon named Digital Pioneer at PM Society awards

October 5, 2012
Medical Communications Creative Lynx, GSK, PM Society Digital Awards, digital

A range of innovative digital programmes created by UK pharma companies and agencies were recognised at last night’s PM Society …

Roche and GSK image

Is it really safety first?

October 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …

votrient image

Survival boost for Votrient in mRCC

October 2, 2012
Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …

andrew_witty_gsk

GlaxoSmithKline announces Board changes

September 27, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Witty

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …

The Gateway to Local Adoption Series

Latest content